The latest closing stock price for Adaptive Biotechnologies as of March 25, 2025 is 8.42.
An investor who bought $1,000 worth of Adaptive Biotechnologies stock at the IPO in 2019 would have $-791 today, roughly -1 times their original investment - a -22.97% compound annual growth rate over 6 years.
The all-time high Adaptive Biotechnologies stock closing price was 67.74 on January 22, 2021.
The Adaptive Biotechnologies 52-week high stock price is 9.01, which is 7% above the current share price.
The Adaptive Biotechnologies 52-week low stock price is 2.28, which is 72.9% below the current share price.
The average Adaptive Biotechnologies stock price for the last 52 weeks is 5.10.
An investor who bought $1,000 worth of Adaptive Biotechnologies stock at the IPO in 2019 would have $-791 today, roughly -1 times their original investment - a -22.97% compound annual growth rate over 6 years.
The all-time high Adaptive Biotechnologies stock closing price was 67.74 on January 22, 2021.
The Adaptive Biotechnologies 52-week high stock price is 9.01, which is 7% above the current share price.
The Adaptive Biotechnologies 52-week low stock price is 2.28, which is 72.9% below the current share price.
The average Adaptive Biotechnologies stock price for the last 52 weeks is 5.10.